VSTM Stock Posts

VSTM Verastem7.76-0.30-3.7%

After Hours:7.55-0.21 (-2.7%)

Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

Business WireMon, 29-Dec 4:01 PM

VSTM Verastem7.76-0.30-3.7%

After Hours:7.59-0.17 (-2.2%)

Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

Business WireMon, 29-Dec 4:01 PM

VSTM Verastem8.11-0.40-4.7%

After Hours:7.50-0.61 (-7.5%)

Verastem Oncology Announces Proposed Public Offering of Common Stock

Business WireThu, 13-Nov 4:07 PM